City Center Advisors LLC’s Bristol-Myers Squibb BMY Stock Holding History

City Center Advisors LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,985	Closed	-$270K	–	160
2024 Q2	$270K	Hold	4,985	–	–	0.32%	129
2024 Q1	$270K	Buy	+4,985	New	+$254K	0.32%	129

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

City Center Advisors LLC's BMY Position: Q3 2024 in Review

City Center Advisors LLC sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 4,985 shares — an estimated $270K sold.

City Center Advisors LLC first reported a position in BMY in Q1 2024 and held it in 2 quarters. The position peaked at $270K in Q2 2024. 2,265 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

City Center Advisors LLC reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
City Center Advisors LLC sold 4,985 Bristol-Myers Squibb shares in Q3 2024, an estimated $270K.
City Center Advisors LLC first reported a position in Bristol-Myers Squibb in Q1 2024 and held it in 2 quarters.
City Center Advisors LLC's Bristol-Myers Squibb position peaked at $270K in Q2 2024.
2,265 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on City Center Advisors LLC's 13F filing for Q3 2024, filed 7 Oct 2024.